Media Release Pivotal TACTI-004 (KEYNOTE-F91) Phase III trial evaluating eftilagimod alfa (efti) in first line non-small cell lung cancer continues to build momentum and is recruiting patients at a growing number of activated clinical sites and countriesTrial in Progress poster for TACTI-004 presented at the World Conference on Lung Cancer (WCLC) 2025, where physician feedback continued to be encouragingPositive feedback received from the FDA regarding future late-stage clinical development of efti in first ...

MIAMI, NEW YORK and WASHINGTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Siebert Financial Corp. (NASDAQ: SIEB) today announced the opening of a Washington, D.C. office to support its expanding Capital Markets and Investment Banking team. Located at 3000 K Street, N.W., Suite 245, Washington, D.C., the new office will be led by Daniel M. Ondeck, Head of Institutional Sales, who works closely with Siebert’s investment bankers on origination and execution across public and private markets, as well as by newly appoin ...

Core Insights - Hyperion DeFi has announced a strategic partnership with Felix to utilize 500,000 HYPE for launching a custom on-chain perpetual futures market, marking a significant advancement in decentralized finance [1][2][3] Group 1: Partnership and Product Development - The HYPE Asset Use Service (HAUS) agreement allows Hyperion DeFi to support Felix in managing a new market using the HIP-3 framework, which facilitates the creation of markets for non-crypto assets [2][3] - This partnership is expected to expand Hyperliquid's product offerings and user base while generating new revenue streams from staked HYPE assets [3][4] Group 2: Market Performance and Future Plans - Felix has achieved a total value locked (TVL) of over $1 billion as of September 2025, indicating strong market traction [4][11] - Felix plans to further integrate its DeFi infrastructure into the development of Felix Exchange, aiming to enhance liquidity access and stablecoin minting [4][5] Group 3: Hyperliquid Platform and HYPE Token - Hyperliquid is a next-generation blockchain designed for high-frequency trading, featuring on-chain perpetual futures and spot order books with rapid transaction times [6] - The HYPE token serves as the native currency of Hyperliquid, with over 30 million HYPE autonomously purchased and sequestered by the blockchain as of October 2025 [7][8]

CUPERTINO, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will participate in Spartan Capital Securities Second Annual Investor Conference on November 3, 2025, in ...

SAN DIEGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ™ (aceclidine ophthalmologic solution) 1.44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia in adults, today announced that it will host a webcast on Wednesday, November 5, 2025, at 8:30 a.m. EST to report its third quarter 2025 financial results and recent corporate highlights. To particip ...

New lighting technology delivers full-spectrum, Far Red, and UV light beneath canopy to increase yield, boost flavor, enhance aroma, and improve overall flower quality for commercial cultivatorsDENVER, Oct. 29, 2025 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGen” or the “Company”), the nation’s largest specialty hydroponic and organic gardening retailer, today announced the launch of its Dialed In™ Tri-Spec Under Canopy Light, a first-of-its-kind lighting solution engineered to boost lowe ...

SAN DIEGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Belite Bio Inc (NASDAQ: BLTE) (“Belite” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the executive management team will present at the Deutsche Bank American Depositary Receipt (ADR) Virtual Investor Conference hosted by VirtualInvestorConferences.com, on November 4, 2025. Details of the presentation are a ...

​​​– Long-time advocate, Paris Hilton, shares her personal ADHD journey from childhood to adulthood to encourage others to speak to their healthcare provider about appropriate treatment options – STOUGHTON, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified biopharmaceutical company, and Paris Hilton, entrepreneur, musician, ​author, and advocate, ​are collaborating ​​to share her personal experience living with attention-deficit/hyperactivity dis ...

MONTREAL, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Harfang Exploration Inc. (TSX-V: HAR) (“Harfang”) and SOQUEM Inc. (“SOQUEM” and together the “Companies”) announce multiple high-grade gold discoveries from their joint summer 2025 exploration program at Harfang’s wholly-owned Menarik West Property (the “Property”), located in Eeyou Istchee James Bay, Québec (see Figure 1). HIGHLIGHTS Discovery of six (6) gold showings, two (2) gold and silver showings, and one (1) copper showing.Top three grab samples returned 55 ...

GREENWICH, Conn., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQG) (NasdaqGS: OXSQH) announced today that it will hold a conference call to discuss third quarter 2025 earnings on Tuesday, November 4, 2025 at 9:00 AM Eastern time. The toll free dial-in number is 1-800-549-8228. There will be a recording available for 30 days after the call. If you are interested in hearing the recording, please dial 1-888-660-6264. The replay pass-code number is 67571#. About O ...